Weight gain in people living with HIV switched to dual therapy: changes in body fat mass
2019
Changes in weight and body composition were assessed in long-term suppressed HIV-infected patients switching to dolutegravir/rilpivirine (n = 37), and compared with similar patients switching to darunavir/lamivudine (n = 17). At month 12, weight significantly increased with dolutegravir/rilpivirine
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
9
Citations
NaN
KQI